Cover Image

CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1

Saved in:

Bibliographic Details
Main Authors:	J.F. Apgar (Author), J.P. Tang (Author), P. Singh (Author), N. Balasubramanian (Author), J.M. Burke (Author), M.R. Hodges (Author), M.A. Lasaro (Author), L. Lin (Author), B.L. Millard (Author), K. Moore (Author), L.S. Jun (Author), S. Sobolov (Author), A.K. Wilkins (Author), X. Gao (Author)
Format:	Book
Published:	Wiley, 2020-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
by: Linda Gailite, et al.
Published: (2018)

Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity
by: Laura Cozzi, et al.
Published: (2022)

Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Radhian Amandito, et al.
Published: (2019)

Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Mohammad Reza Heydari, et al.
Published: (2020)

Genotyping of <i>UGT1A1*</i>80 as an Alternative to <i>UGT1A1*</i>28 Genotyping in Spain
by: Adrián Bravo-Gómez, et al.
Published: (2022)

UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
by: Takano M, et al.
Published: (2017)

CRIGLER- NAJJAR SYNDROME - CASE REPORT
by: Anja Šelih, et al.
Published: (2022)

Cerebellar Symptoms in Crigler-Najjar Type I Disease
by: J Gordon Millichap
Published: (1992)

UGT1A1 gene polymorphisms and jaundice in Indonesian neonates
by: Rinawati Rohsiswatmo, et al.
Published: (2019)

Recent progress and challenges in screening and characterization of UGT1A1 inhibitors
by: Xia Lv, et al.
Published: (2019)

Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes
by: Raju Khatri, et al.
Published: (2021)

Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
by: Chalirmporn Atasilp, et al.
Published: (2022)

211 G to A variation of UGT1A1 and severe neonatal hyperbilirubinemia
by: Yu-Jung Lin, et al.
Published: (2018)

Dosage Adjustment of Irinotecan in Patients with UGT1A1 Polymorphisms: A Review of Current Literature
by: Lia Argevani, et al.
Published: (2020)

UGT1A1*6 mutation associated with the occurrence and severity in infants with prolonged jaundice
by: Zhe Yang, et al.
Published: (2022)

Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia
by: Hui Yang, et al.
Published: (2016)

UGT1A1 sequence variants and bilirubin levels in early postnatal life: a quantitative approach
by: Matern Dietrich, et al.
Published: (2011)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022)

Perioperative management of a patient with hemophilia A and crigler-najjar syndrome
by: Debesh Bhoi, et al.
Published: (2013)

Case report: Crigler-Najjar syndrome type 1 in Croatia-more than a one in a million: a case series
by: Matea Kovačić Perica, et al.
Published: (2023)

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
by: Panagopoulos P, et al.
Published: (2017)

The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility
by: Zijin Li, et al.
Published: (2020)

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
by: Xiaoxia Shi, et al.
Published: (2019)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
by: Naidoo A, et al.
Published: (2017)

Regulation of High-Altitude Hypoxia on the Transcription of CYP450 and UGT1A1 Mediated by PXR and CAR
by: Ya-bin Duan, et al.
Published: (2020)

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine
by: Sofía Calleja, et al.
Published: (2023)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
by: Ya-Di Zhu, et al.
Published: (2021)

An ultra-sensitive and easy-to-use assay for sensing human UGT1A1 activities in biological systems
by: Ya-Di Zhu, et al.
Published: (2020)

ГЕННИЙ ПОЛІМОРФІЗМ G211A ГЕНУ UGT1A1 ТА ПРОЛОНГОВАНА НЕОНАТАЛЬНА ЖОВТЯНИЦЯ
by: O. Yablon, et al.
Published: (2016)

Association of G71R Mutation of the UGT1A1 Gen with Neonatal Hyper Bilirubinemia in the Iranian Population
by: Ebrahim Dastgerdy, et al.
Published: (2012)

Investigating Whether Screening or Testing for the Variation Status of UGT 1A1 Gene is Helpful in Managing Neonatal Hyperbilirubinemia
by: Yao-Jong Yang
Published: (2020)

Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
by: Sarah Glewis, et al.
Published: (2023)

Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center
by: Megan Muldoon, et al.
Published: (2024)

A Case of Adult Hereditary Spherocytosis Concomitant with Gilbert Syndrome Caused by Mutations in SPTB and UGT1A1
by: Gou Y, et al.
Published: (2024)

Management of a pregnancy with Crigler-Najjar syndrome type 2: a case report
by: Erkan Çağlıyan, et al.
Published: (2023)

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials
by: Eva González-Iglesias, et al.
Published: (2024)

Cost-Effectiveness of UGT1A1*28 Genotyping in Preventing Severe Neutropenia Following FOLFIRI Therapy in Colorectal Cancer.
by: Solen Pichereau, et al.
Published: (2011)

UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China
by: Hui Yang, et al.
Published: (2021)

Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen
by: Zhu X, et al.
Published: (2021)

Mild Crigler-Najjar Syndrome with Progressive Liver Disease-A Multicenter Retrospective Cohort Study
by: Norman Junge, et al.
Published: (2023)